MedPath

M.D. ANDERSON CANCER CENTER

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Role of Diet on the Microbiome of the Digestive System

Recruiting
Conditions
Colorectal Carcinoma
First Posted Date
2020-12-14
Last Posted Date
2024-11-11
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
30
Registration Number
NCT04666727
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Phase 1
Recruiting
Conditions
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndrome
Interventions
First Posted Date
2020-12-07
Last Posted Date
2024-12-31
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
52
Registration Number
NCT04655755
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study

Completed
Conditions
COVID-19 Infection
Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm
Interventions
Other: Questionnaire Administration
First Posted Date
2020-12-03
Last Posted Date
2022-01-14
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
80
Registration Number
NCT04652505
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials

Active, not recruiting
Conditions
Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm
Neuropathy
COVID-19 Infection
Interventions
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
First Posted Date
2020-12-02
Last Posted Date
2024-10-21
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
274
Registration Number
NCT04650178
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Effect of Diet on the Immune System in Patients With Stage III-IV Melanoma Receiving Immunotherapy, DIET Study

Phase 2
Active, not recruiting
Conditions
Clinical Stage III Cutaneous Melanoma AJCC v8
Pathologic Stage III Cutaneous Melanoma AJCC v8
Pathologic Stage IV Cutaneous Melanoma AJCC v8
Unresectable Melanoma
Clinical Stage IV Cutaneous Melanoma AJCC v8
Metastatic Melanoma
Interventions
Other: Dietary Intervention
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
First Posted Date
2020-11-27
Last Posted Date
2024-10-26
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
50
Registration Number
NCT04645680
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Parent and Family Oriented Support Interventions for the Facilitation of Weight Loss in African American Families

Not Applicable
Recruiting
Conditions
Obesity-Related Malignant Neoplasm
Interventions
Other: Educational Activity
Other: Informational Intervention
Other: Educational Intervention
Other: Questionnaire Administration
Procedure: Support Group Therapy
First Posted Date
2020-11-25
Last Posted Date
2024-03-08
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
1200
Registration Number
NCT04644224
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

The Rise in Robotic Atypical Segmentectomies

Recruiting
Conditions
Lung Carcinoma
Interventions
Other: Electronic Health Record Review
First Posted Date
2020-11-25
Last Posted Date
2024-03-26
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
600
Registration Number
NCT04644952
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

Active, not recruiting
Conditions
Endometrial Carcinoma
Malignant Uterine Neoplasm
Uterine Corpus Cancer
Uterine Corpus Sarcoma
Interventions
Other: Questionnaire Administration
First Posted Date
2020-11-18
Last Posted Date
2024-12-09
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
310
Registration Number
NCT04634617
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers

Recruiting
Conditions
Malignant Digestive System Neoplasm
Interventions
Other: Electronic Health Record Review
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
First Posted Date
2020-11-16
Last Posted Date
2024-07-26
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
150
Registration Number
NCT04629677
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Phase 2
Recruiting
Conditions
WHO Grade II Glioma
Anaplastic Astrocytoma, IDH-Wildtype
Anaplastic Oligodendroglioma
Oligodendroglioma
Anaplastic Oligoastrocytoma
WHO Grade III Glioma
Diffuse Astrocytoma, IDH-Wildtype
Glioblastoma
Oligoastrocytoma
Interventions
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Radiation: Radiation Therapy
Drug: Temozolomide
First Posted Date
2020-11-10
Last Posted Date
2025-01-01
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
40
Registration Number
NCT04623931
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath